Cadron I - Search Results

1

Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer.

Cadron I, Jakobsen A, Vergote I. Cadron I, et al. Gynecol Obstet Invest. 2005;59(3):126-9. doi: 10.1159/000082750. Epub 2004 Dec 14. Gynecol Obstet Invest. 2005. PMID: 15604591 Clinical Trial.

2

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Among authors: cadron i. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

3

The diagnostic problem of endometrial stromal sarcoma: report on six cases.

Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I. Amant F, et al. Among authors: cadron i. Gynecol Oncol. 2003 Jul;90(1):37-43. doi: 10.1016/s0090-8258(03)00207-5. Gynecol Oncol. 2003. PMID: 12821339 Review.

4

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.

Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I. Amant F, et al. Among authors: cadron i. Gynecol Oncol. 2005 Aug;98(2):274-80. doi: 10.1016/j.ygyno.2005.04.027. Gynecol Oncol. 2005. PMID: 15972232

5

The management of borderline tumours of the ovary.

Cadron I, Amant F, Van Gorp T, Neven P, Leunen K, Vergote I. Cadron I, et al. Curr Opin Oncol. 2006 Sep;18(5):488-93. doi: 10.1097/01.cco.0000239889.98289.ce. Curr Opin Oncol. 2006. PMID: 16894298 Review.

6

The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer.

Cadron I, Leunen K, Amant F, Van Gorp T, Neven P, Vergote I. Cadron I, et al. Gynecol Oncol. 2007 Aug;106(2):354-61. doi: 10.1016/j.ygyno.2007.04.003. Epub 2007 May 11. Gynecol Oncol. 2007. PMID: 17499348

7

Management of borderline ovarian neoplasms.

Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Cadron I, et al. J Clin Oncol. 2007 Jul 10;25(20):2928-37. doi: 10.1200/JCO.2007.10.8076. J Clin Oncol. 2007. PMID: 17617524 Review.

8

Chemotherapy for recurrent cervical cancer.

Cadron I, Van Gorp T, Amant F, Leunen K, Neven P, Vergote I. Cadron I, et al. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S113-8. doi: 10.1016/j.ygyno.2007.07.004. Epub 2007 Sep 4. Gynecol Oncol. 2007. PMID: 17804044 Review.

9

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view.

Vergote I, Amant F, Leunen K, Cadron I, Van Gorp T, Neven P, Berteloot P. Vergote I, et al. Among authors: cadron i. Oncologist. 2008 Apr;13(4):410-4. doi: 10.1634/theoncologist.2007-0224. Oncologist. 2008. PMID: 18448555 Free article.

10

Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients.

Vergote I, Pouseele B, Van Gorp T, Vanacker B, Leunen K, Cadron I, Neven P, Amant F. Vergote I, et al. Among authors: cadron i. Acta Obstet Gynecol Scand. 2008;87(7):783-7. doi: 10.1080/00016340802146946. Acta Obstet Gynecol Scand. 2008. PMID: 18696278 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters